These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38754899)

  • 1. Enhancing SARS-CoV-2 surveillance in Malawi using telephone syndromic surveillance from July 2020 to April 2022.
    Woelk G; Maphosa T; Machekano R; Chauma-Mwale A; Makonokaya L; Zimba SB; Chamanga RK; Nyirenda R; Auld A; Kim E; Sampathkumar V; Ahimbisibwe A; Kalitera L; Kim L; Maida A
    BMJ Glob Health; 2024 May; 9(5):. PubMed ID: 38754899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of Janssen Ad26.COV.S and Astra Zeneca AZD1222 COVID-19 Vaccines among Mobile Phone Users in Malawi: Findings from a National Mobile-Based Syndromic Surveillance Survey, July 2021 to December 2021.
    Makonokaya L; Kapanda L; Woelk GB; Chauma-Mwale A; Kalitera LU; Nkhoma H; Zimba S; Chamanga R; Golowa C; Machekano R; Maphosa T
    Int J Environ Res Public Health; 2023 Nov; 20(23):. PubMed ID: 38063553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol to implement a syndromic surveillance survey of COVID-19 in Malawi.
    Maphosa T; Woelk G; Baack BN; Kim E; Machekano R; Mwale AC; Kalua T; Zimba S; Kanyenda Chamanga R; Maida A; Auld A; Azman AS; Oziemkowska M; Sunguti J; Golowa C; Kapanda L; Nkhoma H; Sampathkumar V; Ahimbisibwe A; Kalitera L; Masina E; Lumala R; Kudiabor K; Joaki Z; Muchuchuti C; Mengezi TH; Nyirenda R; Guay L
    Public Health Pract (Oxf); 2022 Dec; 4():100339. PubMed ID: 36408480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.
    Sudre CH; Keshet A; Graham MS; Joshi AD; Shilo S; Rossman H; Murray B; Molteni E; Klaser K; Canas LD; Antonelli M; Nguyen LH; Drew DA; Modat M; Pujol JC; Ganesh S; Wolf J; Meir T; Chan AT; Steves CJ; Spector TD; Brownstein JS; Segal E; Ourselin S; Astley CM
    Lancet Digit Health; 2021 Sep; 3(9):e577-e586. PubMed ID: 34305035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data.
    Barchuk A; Skougarevskiy D; Kouprianov A; Shirokov D; Dudkina O; Tursun-Zade R; Sergeeva M; Tychkova V; Komissarov A; Zheltukhina A; Lioznov D; Isaev A; Pomerantseva E; Zhikrivetskaya S; Sofronova Y; Blagodatskikh K; Titaev K; Barabanova L; Danilenko D
    PLoS One; 2022; 17(6):e0266945. PubMed ID: 35704649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey.
    Pouwels KB; House T; Pritchard E; Robotham JV; Birrell PJ; Gelman A; Vihta KD; Bowers N; Boreham I; Thomas H; Lewis J; Bell I; Bell JI; Newton JN; Farrar J; Diamond I; Benton P; Walker AS;
    Lancet Public Health; 2021 Jan; 6(1):e30-e38. PubMed ID: 33308423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Web and phone-based COVID-19 syndromic surveillance in Canada: A cross-sectional study.
    Lapointe-Shaw L; Rader B; Astley CM; Hawkins JB; Bhatia D; Schatten WJ; Lee TC; Liu JJ; Ivers NM; Stall NM; Gournis E; Tuite AR; Fisman DN; Bogoch II; Brownstein JS
    PLoS One; 2020; 15(10):e0239886. PubMed ID: 33006990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Sentinel Surveillance Platforms for Monitoring SARS-CoV-2 Activity: Evidence From Analysis of Kenya Influenza Sentinel Surveillance Data.
    Owusu D; Ndegwa LK; Ayugi J; Kinuthia P; Kalani R; Okeyo M; Otieno NA; Kikwai G; Juma B; Munyua P; Kuria F; Okunga E; Moen AC; Emukule GO
    JMIR Public Health Surveill; 2024 Mar; 10():e50799. PubMed ID: 38526537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early public adherence with and support for stay-at-home COVID-19 mitigation strategies despite adverse life impact: a transnational cross-sectional survey study in the United States and Australia.
    Czeisler MÉ; Howard ME; Robbins R; Barger LK; Facer-Childs ER; Rajaratnam SMW; Czeisler CA
    BMC Public Health; 2021 Mar; 21(1):503. PubMed ID: 33722226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of maternal and neonatal outcomes of COVID-19 before and after SARS-CoV-2 omicron emergence in maternity facilities in Malawi (MATSurvey): data from a national maternal surveillance platform.
    Mndala L; Monk EJM; Phiri D; Riches J; Makuluni R; Gadama L; Kachale F; Bilesi R; Mbewe M; Likaka A; Chapuma C; Kumwenda M; Maseko B; Ndamala C; Kuyere A; Munthali L; Henrion MYR; Masesa C; Lissauer D
    Lancet Glob Health; 2022 Nov; 10(11):e1623-e1631. PubMed ID: 36155136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
    Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
    Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing suicidality during the SARS-CoV-2 pandemic: Lessons learned from adaptation and implementation of a telephone-based suicide risk assessment and response protocol in Malawi.
    Landrum KR; Akiba CF; Pence BW; Akello H; Chikalimba H; Dussault JM; Hosseinipour MC; Kanzoole K; Kulisewa K; Malava JK; Udedi M; Zimba CC; Gaynes BN
    PLoS One; 2023; 18(3):e0281711. PubMed ID: 36930620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When the COVID-19 Pandemic Surges during Influenza Season: Lessons Learnt from the Sentinel Laboratory-Based Surveillance of Influenza-Like Illness in Lombardy during the 2019-2020 Season.
    Galli C; Pellegrinelli L; Bubba L; Primache V; Anselmi G; Delbue S; Signorini L; Binda S; Cereda D; Gramegna M; Pariani E; The Ili Sentinel Physicians Group
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33923819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey.
    Adorni F; Prinelli F; Bianchi F; Giacomelli A; Pagani G; Bernacchia D; Rusconi S; Maggi S; Trevisan C; Noale M; Molinaro S; Bastiani L; Fortunato L; Jesuthasan N; Sojic A; Pettenati C; Tavio M; Andreoni M; Mastroianni C; Antonelli Incalzi R; Galli M
    JMIR Public Health Surveill; 2020 Sep; 6(3):e21866. PubMed ID: 32650305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
    Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
    J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.